MedImmune begins first-in-human study of MEDI-5083 alone and with durvalumab in solid tumors April 20, 2017
Argos updates status of ADAPT phase III trial of rocapuldencel-T in metastatic renal cell carcinoma April 19, 2017
OncoMed reports endpoint not met in tarextumab study, discontinuation of brontictuzumab trial April 19, 2017
FDA grants accelerated approval to Tecentriq for bladder cancer not treatable with cisplatin April 18, 2017
National Immunotherapy Coalition formed to accelerate next-generation standard of care in cancer April 12, 2017
RSS